PENG Block vs. ESP Block for Pediatric Hip Surgery

Poznan University of Medical Sciences (PUMS)

Status and phase: Completed; Phase 4

Conditions: Hip Injuries; Hip Fractures; Hip Disease; Hip Dysplasia

Treatments: Drug: Erector Spinae Plane Block using 0.2% ropivacaine; Drug: Pericapsular nerve group block using 0.2% ropivacaine; Other: Standard care

Study type: Interventional

Funder types: Other

Identifiers

NCT06087549

4/2023

Details and patient eligibility

About

The study compares the effectiveness and safety of the pericapsular nerve blockade vs. ESPB in pediatric patients who underwent hip surgeries.

Full description

The study compares the effectiveness and safety of the pericapsular nerve blockade vs. ESPB in pediatric patients who underwent hip surgeries. In addition, we aim to determine the optimal volume of local anesthetics needed to achieve a satisfactory level of analgesia.

Enrollment: 90 patients

Sex: All

Ages: 2 months to 12 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• pediatric patients aged between 0-12 years who will undergo hip surgery

Exclusion criteria

• a history of chronic pain use of gabapentin/pregabalin for > 3 months opioid use > 1 repeated opioid prescription in the last three months
• morbid obesity (BMI > 99th percentile)
• Infection at block application area
• coagulopathy

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

90 participants in 3 patient groups

Control group

Active Comparator group

Description:

regional anesthesia: spinal anesthesia - 0,1ml/kg 0,5% ropivacaine

Treatment:

Other: Standard care

Pericapsular nerve group block (PENG) group

Active Comparator group

Description:

regional anesthesia: spinal anesthesia - 0,1ml/kg 0,5% ropivacaine + PENG block - 0.5mL/kg 0.2% ropivacaine, max. 20mL

Treatment:

Drug: Pericapsular nerve group block using 0.2% ropivacaine

Erector Spinae Plane Block (ESPB) group

Active Comparator group

Description:

regional anesthesia: spinal anesthesia - 0,1ml/kg 0,5% ropivacaine + ESP block - 0.5mL/kg 0.2% ropivacaine, max. 20mL

Treatment:

Drug: Erector Spinae Plane Block using 0.2% ropivacaine